Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Benign Prostate Disease
9%
Cancer Therapy
9%
Cancer Tissue
9%
Cancer-specific Survival
9%
DcR1
9%
DcR2
9%
Death Receptor
18%
Decoy Receptor
18%
Decreased Expression
9%
Epithelial Tumor
9%
Epithelium
9%
Expression Pattern
9%
FLICE
9%
Inhibitory Proteins
9%
Ligand Pathways
9%
Ligand-receptor Binding
9%
Multiple Tumors
9%
Ovarian Cancer
9%
Overall Survival
9%
Patients with Prostate Cancer
9%
Pro-apoptotic
18%
Prognostic Marker
9%
Prostate Cancer
100%
Prostate Cancer Patients
9%
Prostate Tissue
9%
Protein Expression
9%
Receptor Decoy
9%
Recurrence-free Survival
100%
Stromal Proteins
9%
Stromal Tumor
100%
Tissue Microarray
9%
Tumor Immune Surveillance
9%
Tumor Microenvironment
27%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
100%
Tumor Subtype
9%
Medicine and Dentistry
Cancer Survival
10%
Cancer Therapy
10%
Cancer Tissue
10%
Death Receptor
20%
Epithelioma
10%
FLICE Inhibitory Protein
10%
Immunosurveillance
10%
Neoplasm
10%
Ovarian Cancer
10%
Overall Survival
10%
Prostate Cancer
100%
Prostate Tissue
10%
Protein Expression
10%
Proteus Syndrome
10%
Receptor
20%
Recurrence Free Survival
100%
Stromal Tumor
100%
Tissue Microarray
10%
Tumor Microenvironment
30%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
10%
Biochemistry, Genetics and Molecular Biology
Cancer Survival
9%
Caspase 8
9%
Immunosurveillance
9%
Overall Survival
9%
Programmed Cell Death
100%
Protein Expression
9%
Recurrence Free Survival
100%
Tissue Microarray
9%
Tumor Necrosis Factor
100%